Nursing Responsibilities for Drug Monitoring

A drug can be dosed correctly, given safely, and still harm the patient — the difference between a good outcome and a disaster is what you monitor after it's given.

Nursing drug monitoring is the systematic assessment of therapeutic effectiveness and adverse responses after medication administration. It bridges pharmacokinetics and pharmacodynamics into bedside action. Peak levels are drawn after the distribution phase is complete to confirm the drug reaches therapeutic concentration; trough levels are drawn immediately before the next dose to confirm the drug clears enough to avoid toxicity. For aminoglycosides, the peak is typically drawn 30 minutes after a 30-minute IV infusion ends; the trough is drawn 30 minutes before the next dose. For narrow therapeutic index (NTI) drugs, monitoring is non-negotiable because small dose changes produce large effect changes. Key NTI drugs and their ranges: gentamicin/tobramycin peak 5–10 mcg/mL, trough <2 mcg/mL; vancomycin trough 10–20 mcg/mL (with AUC/MIC-guided dosing now preferred per 2020 guidelines); lithium 0.6–1.2 mEq/L (toxicity above 1.5); digoxin 0.5–2.0 ng/mL; phenytoin 10–20 mcg/mL; theophylline 10–20 mcg/mL; warfarin is monitored via INR (target 2–3 for most indications), not serum drug levels. Beyond drug levels, monitoring includes organ function labs tied to the drug's clearance pathway: creatinine and BUN for nephrotoxic drugs, hepatic enzymes for hepatotoxic drugs, and CBC for myelosuppressive agents. The nurse correlates subjective reports (e.g., tinnitus with aminoglycosides, metallic taste with lithium) with objective data to detect toxicity early.

Key Distinctions

Don't confuse peak and trough timing — peak measures maximum concentration (drawn after distribution is complete), trough measures minimum (drawn right before the next dose). Therapeutic drug monitoring requires a provider order and precise draw times relative to the dose; if timing is off, the result is meaningless. A drug level within range doesn't guarantee safety — clinical signs of toxicity override the number. Don't confuse drug toxicity with disease exacerbation: lithium toxicity causes coarse tremor, vomiting, and confusion, which differ from bipolar mania symptoms like pressured speech and grandiosity.

Clinical Pearl

Trough before, peak after. If you draw the trough late or the peak early, the levels lie — and you can't unpoison a patient with a falsely reassuring lab.